While vaccines based on inactivated Apx toxins (toxoids) are effective in reducing the morbidity associated with infection [9–12] yet unable to prevent colonisation of the lungs, their use pose a potential threat inducing infection by asymptomatic carriers [7, 11, 13]. Here, APEX1 is linked to infection.